The causative role of aberrant Hh signalling in BCC is underlined by the fact that approximatively 70–80%, 20%, and 8% have PTCH1, SMO, and SUFU driver mutations respectively [15,16,17]. The gene discussed is SMO; the disease is skin basal cell carcinoma.